Application
GOLGA2L1 Antibody (C-term) western blot analysis in A549 cell line lysates (35ug/lane).This demonstrates the GOLGA2L1 antibody detected the GOLGA2L1 protein (arrow).Application
GOLGA2L1 Antibody (C-term) flow cytometric analysis of A549 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | GOLGA2L1 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | GOLGA2P5; GOLGA2B; GOLGA2L1; Putative golgin subfamily A member 2B; Golgin subfamily A member 2-like protein 1 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | GOLGA2B GOLGA2L1 |
|---|---|
| Alternative Names | GOLGA2P5 GOLGA2B GOLGA2L1 Putative golgin subfamily A member 2B Golgin subfamily A member 2-like protein 1 |
| Molecular Weight(MW) | 15482 Da |
| Tissue Specificity | This GOLGA2L1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 90-120 amino acids from the C-terminal region of human GOLGA2L1. |
| Nucleotide Accession | NP_060070.1 |
|---|
Application
GOLGA2L1 Antibody (C-term) western blot analysis in A549 cell line lysates (35ug/lane).This demonstrates the GOLGA2L1 antibody detected the GOLGA2L1 protein (arrow).
Application
GOLGA2L1 Antibody (C-term) flow cytometric analysis of A549 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
